NCT00215254View on ClinicalTrials.gov

Quetiapine in Social Anxiety Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

February 28, 2006

Conditions

Social Anxiety Disorder

Interventions

DRUG

quetiapine

Trial Locations (1)

27705

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Duke University

OTHER